Immunicum Announces Positive Review by Data Safety Monitoring Board for Phase Ib Part of ILIAD Study

NEXT STORY
Allarity Therapeutics and Lantern Pharma Enter into Agreement for Future Clinical Development of Irofulven
PREV STORY
Basilea’s partner Asahi Kasei Pharma prepares NDA filing for the marketing authorization of isavuconazole in Japan based on positive phase 3 study results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Medical Gloves Market to Witness a CAGR of 6.4% during the 2018-2024: Energias Market Research Private Limited

author_avatar
NASDAQ Market News

Correction: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine

author_avatar
NASDAQ Market News

ObsEva SA Announces Initiation of Phase 3 IMPLANT 4 Trial of Nolasiban in Europe, Canada and Russia for Improving IVF Outcomes

Geneva, Switzerland and Boston, MA – November 28, 2018 – ObsEva SA (NASDAQ: OBSV ...

author_avatar
NASDAQ Market News